Cargando…
In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
Shed cells or disrupted parts of the biofilm may enter the circulation causing serious and very hard to treat biofilm-associated infections. The activity of antimicrobial agents against the shed cells/disrupted biofilms is largely unknown. METHODS: We studied the in vitro susceptibility of intact an...
Autores principales: | El-Azizi, Mohamed, Rao, Suma, Kanchanapoom, Termkiat, Khardori, Nancy |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC546415/ https://www.ncbi.nlm.nih.gov/pubmed/15638934 http://dx.doi.org/10.1186/1476-0711-4-2 |
Ejemplares similares
-
Quinupristin/Dalfopristin-induced Sweet’s Syndrome
por: Choi, Hye Sook, et al.
Publicado: (2003) -
Susceptibility of Glycopeptide-Resistant Enterococci to Linezolid, Quinupristin/dalfopristin, Tigecycline and Daptomycin in a Tertiary Greek Hospital
por: Maraki, Sofia, et al.
Publicado: (2014) -
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis
por: Shariati, Aref, et al.
Publicado: (2020) -
Quinupristin/dalfopristin in Staphylococcus aureus endophthalmitis: a case report
por: Hernandez-Da Mota, Sergio E
Publicado: (2011) -
Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China
por: Wang, Shanshan, et al.
Publicado: (2016)